The FDA has granted accelerated approval to Datroway for adults with previously-treated, locally advanced or metastatic EGFR-mutated NSCLC.

In 2024, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair ...

Meet the experts: Chesahna Kindred, MD, is a dermatologist in Marriottsville, Maryland, who specializes in hair loss. Melissa Piliang, MD, is a dermatologist and hair loss specialist at the Cleveland ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

Matthew Riccardi was just 11 years old when he was diagnosed with the same condition: alopecia areata, an autoimmune disorder that targets hair follicles. Much like Campbell, the then-sixth grader ...

Dato-DXd was granted accelerated approval for use in adults with EGFR-mutated NSCLC after EGFR-targeted therapy and platinum-based chemotherapy.

You may know finasteride is a medication commonly used to treat male pattern baldness (androgenetic alopecia). But did you know it comes in different forms?

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop it in its tracks.

Available through forhers.com, this gummy combines prescription-strength minoxidil, the only FDA-approved ingredient for female hair loss, with biotin, a popular vitamin for supporting healthy skin, ...

ALEXANDRIA, VA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- ● The NPF Seal of Recognition highlights products that prove a commitment to being safe and non-irritating for people with psoriasis ...

The FDA has approved Sun Pharma’s Leqselvi (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. The novel, oral Janus kinase (JAK) inhibitor targets the JAK1 and JAK2 ...

The approval is based on data from two multicenter, randomized, double-blind, placebo-controlled Phase 3 clinical trials THRIVE-AA1 and THRIVE-AA2, which enrolled a total of 1,220 patients with ...